Trials / Not Yet Recruiting
Not Yet RecruitingNCT07456059
A Study to Evaluate EDG-7500 in Caucasian and Japanese Adults
A Phase 1, Single-center, Open-label, Study to Investigate the Safety, Tolerability, and Pharmacokinetics of a Single Dose and Multiple Doses of EDG-7500 in Healthy Adult Caucasian and Japanese Participants
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Edgewise Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this Phase 1 study is to understand and compare the amount of EDG-7500 in the blood after single and multiple doses in Japanese and Caucasian adults. The safety of EDG-7500 in these adult participants will also be evaluated in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EDG-7500 | Solid oral formulation of EDG-7500 |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2026-03-06
- Last updated
- 2026-03-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07456059. Inclusion in this directory is not an endorsement.